Harnessing Technology for Advancements in Veterinary Vaccines

The Veterinary vaccines market size is expected to be valued at USD 7.6 Billion in 2024 and reach USD 9.93 Billion by 2029, growing at a CAGR of 5.5 % from 2024 to 2029.

Veterinary vaccines are designed to protect animals from diseases and enhance their immune system to fight future infections caused by various diseases. They are vital in managing animal health protection by preventing and fighting various diseases.

Global Veterinary Vaccines Market Report Scope:
• Market Size (2029): USD 9.93 Billion
• Market Size (2024): USD 7.6 Billion
• CAGR (2024 to 2029): 5.5 %
• Base Year: 2023
• Forecast Period: 2024 to 2029
• Segments Analysed: By Type, Production Technologies, and Region
• Geographies Covered: North America, Europe, APAC, Latin America, and Middle East & Africa
• Key Market Players Profiled: Bayer HealthCare AG, Sanofi Animal Health, Inc., Heska Corporation, Indian Immunologicals Ltd., Biogenesis Bago SA, Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health, Inc., Merck & Co. Inc. and Protein Sciences. are playing a dominant role in the Veterinary vaccines market.

Browse full details of the report @ https://www.marketdataforecast.com/market-reports/veterinary-vaccines-market

Key Insights from The Report:

• Based on Type, the livestock vaccine segment captured highest share of the global market in 2023.
• Based on Production Technologies, the Live Attenuated Vaccines segment dominated the market in 2023.

• North America dominated the healthcare analytics market in 2023. Europe accounted for second- highest share of the global Veterinary vaccines market in 2023 and on the other hand, the Asia-Pacific region is estimated to grow at the fastest CAGR during the forecast period.
• AMD Global Veterinary vaccines market Bayer HealthCare AG, Sanofi Animal Health, Inc., Heska Corporation, Indian Immunologicals Ltd., Biogenesis Bago SA, Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Health, Inc., Merck & Co. Inc. and Protein Sciences are dominated the Veterinary vaccines market.

The increasing adoption of pets worldwide and the growing trend of pet humanization are majorly contributing to the global veterinary vaccines market. The rising prevalence of zoonotic diseases worldwide is increasing the adoption of veterinary vaccines among pet owners, fueling the market expansion. According to Forbes Media, in 2022, the total amount of money Americans spent on their pets was USD 132.8 billion, an increase of USD 13.2 billion from the previous year. There is a 10.68% increase compared to 2021 when the total amount spent on pets was USD 123.6 billion. Most people are aware of the importance of animals and their immune systems, which is propelling the growth in the adoption of the number of veterinary vaccines and the growing government support by initiating various awareness programs by colliding with public organizations like the Red Cross supporting the animal health which is expected to augment the global market share growth. The increasing demand for animal-derived food products is another significant factor for market growth as the animal population is rising across various regions. There is a significant increase in the demand for animal-based products, which includes meat, eggs, and dairy products. The demand for meat is high due to its high protein content and essential nutrients. The growing research and development activities, enhancements in the veterinary healthcare industry, and technological advancements in the research sector are all propelling the expansion of the market.

Limited awareness among people from low- and middle-income countries is the primary factor restraining market growth. Most people hesitate to adopt new vaccinations due to animal safety, which slows the adoption of new vaccines by limiting the market growth. The high costs associated with vaccines, maintenance, and storage conditions are estimated to hamper the global market value. The need for skilled professionals to administer vaccinations is a primary obstacle in developing and underdeveloped regions, which hinders market growth. The expensive research and development procedures with limited innovations are estimated to impede the market growth worldwide.

SEGMENTATION INCLUDED IN THIS REPORT:

By Type:
• Livestock Vaccines
o Bovine
o Porcine
o Ovine
o Poultry
o Equine
• Companion Vaccines
o Feline Vaccines
o Canine Vaccines

By Production Technologies:
• Live Attenuated Vaccines
• Inactivated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Subunit Vaccines
• DNA Vaccines
• Conjugate Vaccines
By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Browse Regional Reports:

North America Veterinary Vaccines Market Research Report - Segmented By Type, Technology and Country (U.S, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028) - https://www.marketdataforecast.com/market-reports/north-america-veterinary-vaccines-market

Europe Veterinary Vaccines Market Research Report - Segmented By Type, Technology and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028) - https://www.marketdataforecast.com/market-reports/europe-veterinary-vaccines-market

APAC Animal / Veterinary Vaccines Market Research Report - Segmented By Type, Technology and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028) - https://www.marketdataforecast.com/market-reports/asia-pacific-veterinary-vaccines-market

Latin America Animal / Veterinary Vaccines Market Research Report - Segmented By Type, Technology and Country (Mexico ,Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size,Share, Growth, Trends, & Forecast (2023 to 2028) -https://www.marketdataforecast.com/market-reports/latin-america-veterinary-vaccines-market

Middle East And Africa Veterinary Vaccines Market Research Report - Segmented By Type , Technology, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan and Rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast from (2023 to 2028 )- https://www.marketdataforecast.com/market-reports/middle-east-and-africa-veterinary-vaccines-market

TABLE OF CONTENTS:

1. Introduction
1.1. Market Definition
1.2. Study Deliverables
1.3. Base Currency, Base Year and Forecast Periods
1.4. General Study Assumptions
2. Research Methodology
2.1. Introduction
2.2. Research Phases
2.2.1. Secondary Research
2.2.2 Primary Research
2.2.3. Econometric Modelling
2.2.4. Expert Validation
2.3. Analysis Design
2.4. Study Timeline
3. Overview
3.1. Executive Summary
3.2. Key Inferences
3.3. New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1. Market Drivers
4.2. Market Restraints
4.3. Key Challenges
4.4. Current Opportunities in the Market
5. Market Segmentation
5.1. By Type
5.1.1. Livestock Vaccines
5.1.1.1. Bovine
5.1.1.2. Porcine
5.1.1.3. Ovine
5.1.1.4. Poultry
5.1.1.5. Equine
5.1.1.6. Y-o-Y Growth Analysis, By Livestock Vaccines Type
5.1.1.7. Market Attractiveness Analysis, By Livestock Vaccines Type
5.1.1.8. Market Share Analysis, By Livestock Vaccines Type
5.1.2. Companion Vaccines
5.1.2.1. Feline Vaccines
5.1.2.2. Canine Vaccines
5.1.2.3. Y-o-Y Growth Analysis, By Companion Vaccines Type
5.1.2.4. Market Attractiveness Analysis, By Companion Vaccines Type
5.1.2.5. Market Share Analysis, By Companion Vaccines Type
5.2. By Production Technologies
5.2.1. Live Attenuated Vaccines
5.2.2. Inactivated Vaccines
5.2.3. Recombinant Vaccines
5.2.4. Toxoid Vaccines
5.2.5. Subunit Vaccines
5.2.6. DNA Vaccines
5.2.7. Conjugate Vaccines
5.2.8. Y-o-Y Growth Analysis, By Production Technologies Type
5.2.9. Market Attractiveness Analysis, By Production Technologies Type
5.2.10. Market Share Analysis, By Production Technologies Type
6. Geographical Analysis
6.1. North America
6.1.1. Introduction
6.1.2. US
6.1.3. Canada
6.1.4. Mexico
6.1.5. Rest of North America
6.2. Europe
6.2.1. Introduction
6.2.2. UK
6.2.3. France
6.2.4. Spain
6.2.5. Germany
6.2.6. Italy
6.2.7. Russia
6.2.8. Sweden
6.2.9. Denmark
6.2.10. Switzerland
6.2.11. Netherlands
6.2.12. Turkey
6.2.13. Czech Republic
6.2.14. Rest of Europe
6.3. Asia-Pacific
6.3.1. Introduction
6.3.2. India
6.3.3. China
6.3.4. Japan
6.3.5. South Korea
6.3.6. Australia
6.3.7. New Zealand
6.3.8. Thailand
6.3.9. Malaysia
6.3.10. Vietnam
6.3.11. Philippines
6.3.12. Indonesia
6.3.13. Singapore
6.3.14. Rest of APAC
6.4. Latin America
6.4.1. Introduction
6.4.2. Brazil
6.4.3. Argentina
6.4.4. Chile
6.4.5. Rest of Latin America
6.5. Middle East & Africa
6.5.1. Introduction
6.5.2. KSA
6.5.3. UAE
6.5.4. Israel
6.5.5. Rest of GCC countries
6.5.6. South Africa
6.5.7. Ethiopia
6.5.8. Kenya
6.5.9. Egypt
6.5.10. Sudan
6.5.11. Rest of MEA
7. Strategic Analysis
7.1. PESTLE analysis
7.1.1. Political
7.1.2. Economic
7.1.3. Social
7.1.4. Technological
7.1.5. Legal
7.1.6. Environmental
7.2. Porter's Five analysis
7.2.1. Bargaining Power of Suppliers
7.2.2. Bargaining Power of Consumers
7.2.3. Threat of New Entrants
7.2.4. Threat of Substitute Products and Services
7.2.5. Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1. Bayer HealthCare AG
8.1.1. Overview
8.1.2. Product Analysis
8.1.3. Strategic Evaluation and Operations
8.1.4. Financial analysis
8.1.5. Legal issues
8.1.6. Recent Developments
8.1.7. SWOT analysis
8.1.8. Analyst View
8.2. Bioniche Animal Health Canada
8.3. Sanofi Animal Health, Inc.
8.4. Biogenesis Bago SA
8.5. Heska Corporation
8.6. Indian Immunologicals Ltd.
8.7. Boehringer Ingelheim GmbH
8.8. Zoetis
8.9. Novartis Animal Health, Inc.
8.10. Merck & Co. Inc
8.11. Protein Sciences
9. Competitive Landscape
9.1. Market share analysis
9.2. Merger and Acquisition Analysis
9.3. Agreements, Collaborations and Joint Ventures
9.4. New Product Launches
10. Market Outlook and Investment Opportunities
11. Appendix
11.1. List of Tables
11.2. List of Figures

Contact Us:
MarketDataForecast
www.marketdataforecast.com
Phone: +1-888-702-9626
Email: sales@marketdataforecast.com
5th Floor, Trendz Pride, Patrika Nagar Rd Number 1, HUDA Techno Enclave, HITEC City, Hyderabad, Telangana 500081, India

About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

This release was published on openPR.